Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
April 28, 2025
Driver’s ed: watching HSV co-infection and recombination in vivo
From the Jerome Lab, Vaccine & Infectious Disease Division
Anti-(idio)typical: a new immunogen to vaccinate against RSV
From the McGuire Lab, Vaccine & Infectious Disease Division
¿Necesito otra vacuna de refuerzo contra el SRAS-CoV-2?
Del Dr. Bo Zhang y laboratorios colaboradores, División de Vacunas y Enfermedades Infecciosas
Infectious disease experts propose trials network dedicated to immunocompromised patients
ImmunOptimize workshop convened stakeholders across disciplines to brainstorm infectious disease clinical trials network designed to serve people with weakened immune systems
Engineered HSV can trigger genetic chain reaction, rejigger HSV genes during co-infection
Proof-of-concept work raises hope that ‘gene drive’ could one day form basis of curative gene therapy for herpes
A promising HIV vaccine candidate gets a little help
New strategy stirs a robust response from T cells tracked by McElrath lab
Researchers advance development of potential Epstein-Barr virus vaccines
Stakes raised as common virus linked to more diseases
5 reasons why a cancer research center has virology expertise
Pathogens can cause diseases, the immune system can fight them
Vaccines stop COVID-19 symptoms, but do they stop transmission?
Researchers mull options, including college dorm studies and 'human challenge' trials, to find answer
No flu yet, but still — get your shot
COVID-19 pandemic makes prevention measures against influenza all the more important
Dr. Anna Wald lauded by Infectious Diseases Society
Virologist will deliver prestigious John F. Enders Lecture during annual conference
Computer model offers insights on COVID-19 super-spreading
New research compares transmission patterns of SARS-CoV-2 with those of influenza
'Part of the solution': Donors take action to advance COVID-19 research
Philanthropic support for research grows even as the coronavirus forces creative reimagining of traditional fundraising activities
What happens when cancer patients get COVID-19?
Large new observational study of nearly 1,000 patients breaks down who’s most at risk with coronavirus, highlights need for additional care
Your vote needed! Hutch science competes in 'STAT Madness'
Studies by Drs. Justin Taylor, Robert Bradley are finalists in annual competition for best biomedical advance
Tracking the coronavirus epidemic from Wuhan to the world
Scientists and public health officials worldwide collaborate to understand COVID-19 and slow its spread
The present and future of science intersect in Seattle
Highlights from the annual meeting of the American Association for the Advancement of Science
Does CAR T-cell therapy leave patients vulnerable to infection?
$3.3M Cancer Moonshot grant to study how immunotherapy impacts patients’ ability to fight off bugs
Hutch influenza experts assay the latest science
Flu shots remain your best bet for protection, but no guarantee against infection
Dr. M. Elizabeth ‘Betz’ Halloran elected to National Academy of Medicine
Statistician honored for helping the world anticipate, manage and prevent infectious disease outbreaks